INCB019602
/ Incyte
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 20, 2010
Emergent BioSolutions up on revised forecast. FDA accepts MannKind's NDA. AspenBio falls on failed test
(BioMedReports)
-
Incyte Corporation scheduled its Q2 ‘10 financial results conference call on Aug 5 ‘10;
Anticipated financial results
1 to 1
Of
1
Go to page
1